Jonathan Kay, MD, discusses challenges that patients may experience related to biosimilars for inflammatory conditionsRyan Haumschild, PharmD, MS, MBA: And with those great opportunities biosimilars provide, there are also challenges. Dr Kay, I don’t want to come to you for just challenges, but I feel like I’d love to hear your perspective of some of […]